Skip to content
Review

Brain lipid dysregulation as a driver of energy metabolism failure in Alzheimer's disease.

2026 · International review of neurobiology · Vol 188, pp. 363-396 · 0 citations
Medicine

TL;DR

This chapter addresses the gap and consolidates existing information connecting lipid modifications to metabolic dysfunction in AD, emphasizing molecular pathways and prospective treatment strategies aimed at lipid metabolism to re-establish bioenergetic equilibrium.

View source

Similar papers

Review Open access Sep 2026

Targeting lipid homeostasis for preventive intervention in brain aging and Alzheimer’s disease

Lipids are essential for brain structure and function, contributing to membrane integrity, synaptic activity, signal transduction, and energy metabolism. Converging evidence from human genetics, epidemiology, lipidomics, and neuroimaging indicates that disrupted lipid homeostasis is an early and biologically rele...

L. Berliocchi, M. Grimm, Tobias Hartmann et al. · 0 citations
Review Sep 2026

Astrocyte Lipid Metabolism: From Physiological Homeostasis to Reactive Phenotype Plasticity in Neurodegeneration.

A systematic review of recent advances in astrocyte lipid metabolism is provided, summarizing the fundamental roles of astrocytes in the CNS and focusing on the biosynthesis, degradation, and trafficking mechanisms of fatty acids, cholesterol, and the tightly linked organelles known as lipid droplets.

Hao Chen, Xi-Ning Cui, Meng-Yan Deng · 0 citations
Review Sep 2026

Lipid regulation of mitochondrial function in metabolic Diseases: Lipotoxic mediators and therapeutic targeting.

Lipid dysregulation is a key driver of chronic metabolic and degenerative diseases. However, lipid abnormalities and mitochondrial dysfunction are often examined separately, with limited attention given to their mechanistic links. As the central hub of energy metabolism, mitochondria continuously adapt their structure,...

Hao Cui, Hong-Xing Li, Wei-Hua Wang et al. · 0 citations
Review Sep 2026

Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer’s disease: mechanisms, neuroimmune crosstalk, and therapeutic potential

This review critically examines the molecular and cellular mechanisms underlying PE-mediated adipose–brain crosstalk in obesity-associated Alzheimer’s disease, with emphasis on mitochondrial dysfunction, blood–brain barrier disruption, ferroptosis, membrane remodeling, and microglial activation.

Mumtaz Ahmad, Moh Aijaz, Mohamamd Anas Ansari et al. · 0 citations
Review Open access Sep 2026

Reframing Alzheimer’s Disease Through a Redox-Metabolic Framework

Alzheimer’s disease (AD) has been conceptualised as a proteinopathy driven by amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles. AD should not be understood as exclusively a proteinopathy or a metabolic/redox disorder, but as a network of interacting processes in which metabolic dysfunction, mitocho...

Amador Velázquez de Castro-Bono, G. Castro-Luna, J. Guil-Guerrero · 0 citations
Review Sep 2026

From physiological homeostasis to pathological injury: Cell-specific functions, imbalance mechanisms, and disease biomarker value of brain lipid droplets.

Lipid droplets (LDs) are versatile cellular structures that consist of a core made of neutral lipids, surrounded by a monolayer of phospholipid membrane. Beyond energy storage, LDs serve as critical immunometabolic platforms that govern microglial activation states and neuroinflammatory cascades. Their formation and fu...

Qing Zhang, Xiao-Li Liu, Le Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.